FOXC1: A Specific Biomarker for Triple Negative Breast Cancer Diagnosis and Classification

被引：0
|
作者：
Li, Ming [1 ]
Lv, Hong [1 ]
Zhong, Siyuan [1 ]
Zhou, Shuling [1 ]
Li, Anqi [1 ]
Lu, Hongfen [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
107
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [31] HTB50-2 Inhibits Growth and Migration of Triple-negative Breast Cancer via FOSL2/FOXC1 Signaling Axis and Subsequent Ferroptosis
    Liu, Na
    Yin, Wen-ying
    Duan, Wen-qi
    Lyu, Yu-zhu
    Xie, Shan
    Fang, Lei
    Ji, Yan
    Yang, Feng-ying
    Ge, Di
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [32] The significant aberrant expression of FOXC1 as a high specific and sensitive potential biomarker in gastric adenocarcinoma tumor tissues
    Hajjari, Mohammadreza
    Behmanesh, Mehrdad
    Zeinoddini, Mehdi
    GENE THERAPY AND MOLECULAR BIOLOGY, 2013, 15 : 1 - 7
  • [33] Endocan as a prognostic biomarker of triple-negative breast cancer
    Sagara, Atsunobu
    Igarashi, Katsuhide
    Otsuka, Maky
    Kodama, Akihiro
    Yamashita, Mutsumi
    Sugiura, Rei
    Karasawa, Takeshi
    Arakawa, Kazuhiko
    Narita, Michiko
    Kuzumaki, Naoko
    Narita, Minoru
    Kato, Yoshinori
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 269 - 278
  • [34] Classification of triple-negative breast cancer tumors
    Hartung, C.
    Stueckrath, K.
    Hanf, V.
    Lantzsch, T.
    Uleer, C.
    Peschel, S.
    John, J.
    Weigert, E.
    Buchmann, J.
    Buerrig, K. -F.
    Thomssen, C.
    Kantelhardt, E. J.
    Vetter, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 36 - 36
  • [35] BIOMARKER IDENTIFICATION IN TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS
    Mohan, Kabhilan
    Shih, Andrew
    Liew, Anthony
    Khalili, Houman
    Sultan, Gwyneth
    Shapira, Iuliana
    Lee, Annette
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (04) : 920 - 920
  • [36] FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
    Jin, Yanli
    Han, Bingchen
    Chen, Jiongyu
    Wiedemeyer, Ruprecht
    Orsulic, Sandra
    Bose, Shikha
    Zhang, Xiao
    Karlan, Beth Y.
    Giuliano, Armando E.
    Cui, Yukun
    Cui, Xiaojiang
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S758 - S766
  • [37] Endocan as a prognostic biomarker of triple-negative breast cancer
    Atsunobu Sagara
    Katsuhide Igarashi
    Maky Otsuka
    Akihiro Kodama
    Mutsumi Yamashita
    Rei Sugiura
    Takeshi Karasawa
    Kazuhiko Arakawa
    Michiko Narita
    Naoko Kuzumaki
    Minoru Narita
    Yoshinori Kato
    Breast Cancer Research and Treatment, 2017, 161 : 269 - 278
  • [38] Updates on Molecular Classification of Triple Negative Breast Cancer
    Ezenwajiaku N.
    Ma C.X.
    Ademuyiwa F.O.
    Current Breast Cancer Reports, 2018, 10 (4) : 289 - 295
  • [39] Molecular Classification of Triple-Negative Breast Cancer
    Ahn, Sung Gwe
    Kim, Seung Jun
    Kim, Cheungyeul
    Jeong, Joon
    JOURNAL OF BREAST CANCER, 2016, 19 (03) : 223 - 230
  • [40] FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer
    Yanli Jin
    Bingchen Han
    Jiongyu Chen
    Ruprecht Wiedemeyer
    Sandra Orsulic
    Shikha Bose
    Xiao Zhang
    Beth Y. Karlan
    Armando E. Giuliano
    Yukun Cui
    Xiaojiang Cui
    Annals of Surgical Oncology, 2014, 21 : 758 - 766
12345